XML 22 R2.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Current Assets:    
Cash $ 455,366 $ 6,611,928
Accounts receivable, net of allowances of $100,189 and $73,162 2,217,533 1,285,165
Royalties receivable 49,344 50,250
Inventory, net of allowance for obsolescence of $276,603 and $43,650 1,148,253 746,519
Prepaid and other assets 611,817 161,902
Total current assets 4,482,313 8,855,764
Long-Term Assets:    
Property, plant and equipment, net of accumulated depreciation of $124,691 and $60,694 678,589 204,953
Right of use assets - operating lease 467,653 585,251
Intangible assets, net of accumulated amortization of $827,108 and $603,580 3,097,666 1,471,194
Investment in equity securities 1,100,000 0
Total long-term assets 5,343,908 2,261,398
Total assets 9,826,221 11,117,162
Current Liabilities:    
Accounts payable 271,251 337,504
Accounts payable - related party 223,589 68,668
Accrued royalties and expenses 502,191 528,060
Accrued bonus and commissions 2,417,277 1,588,056
Operating lease liability - current 125,587 117,533
Total current liabilities 3,539,895 2,639,821
Long-Term Liabilities:    
Operating lease liability - long term 355,797 481,384
Convertible notes payable - related party 0 1,500,000
Accrued interest - related party 0 103,557
Other long-term liabilities 90,293 0
Total long-term liabilities 446,090 2,084,941
Total liabilities 3,985,985 4,724,762
Shareholders' Equity:    
Series F convertible preferred stock: $10 par value, 1,200,000 shares authorized; none issued and outstanding as of December 31, 2020 and 1,136,815 issued and outstanding as of December 31, 2019 0 11,368,150
Common stock: $0.001 par value, 20,000,000 shares authorized; 6,297,008 issued and outstanding as of December 31, 2020 and 3,571,001 issued and outstanding as of December 31, 2019 6,297 3,571
Additional paid-in capital 13,176,576 (2,081,829)
Accumulated deficit (7,032,242) (2,675,802)
Total Sanara MedTech shareholders' equity 6,150,631 6,614,090
Equity attributable to noncontrolling interest (310,395) (221,690)
Total shareholders' equity 5,840,236 6,392,400
Total liabilities and shareholders' equity $ 9,826,221 $ 11,117,162